Welcome to our dedicated page for Aptargroup SEC filings (Ticker: ATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading AptarGroup’s SEC disclosures often means wading through hundreds of pages on elastomer technology, pharma device trials, and global resin costs. Finding when executives sell shares or how the Pharma segment’s margins shift quarter-to-quarter can be a challenge.
Stock Titan solves this problem by pairing real-time EDGAR feeds with AI-powered summaries. Whether you need the AptarGroup quarterly earnings report 10-Q filing for revenue trends, an AptarGroup 8-K material events explained alert after a plant expansion, or the latest AptarGroup insider trading Form 4 transactions, our platform converts legal jargon into clear insights. Instant notifications surface every AptarGroup Form 4 insider transactions real-time so you never miss key moves by management.
What investors actually use here:
- 10-K & 10-Q – AI highlights segment performance and R&D spending, giving you an AptarGroup annual report 10-K simplified.
- 8-K – One-click summaries keep material developments in context.
- DEF 14A – The AptarGroup proxy statement executive compensation section lets you compare pay against peers.
- Form 4 – Track AptarGroup executive stock transactions Form 4 and spot buying before order book spikes.
From “understanding AptarGroup SEC documents with AI” to in-depth AptarGroup earnings report filing analysis, every document is indexed, summarized, and searchable. Save hours, monitor compliance, and make confident decisions with Stock Titan’s comprehensive coverage of AptarGroup SEC filings explained simply.
AptarGroup (ATR) insider sale by Segment President Touya Gael. The Form 4 reports that on 09/11/2025 Mr. Gael sold a total of 2,500 shares of AptarGroup common stock in two sets of transactions: 2,110 shares at a weighted-average price of $136.1325 and 390 shares at a weighted-average price of $136.0467. Following those reported sales, the filing shows beneficial ownership of 31,853 shares after the first sale and 31,463 shares after the second sale. The filing was signed by an attorney-in-fact on 09/12/2025 and includes explanations that the reported prices are weighted averages across multiple trades.
AptarGroup, Inc. (ATR) filed a Form 144 notifying the proposed sale of 2,500 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $340,297.75 and an approximate sale date of 09/11/2025. The filing reports total outstanding shares of 65,880,522, which gives context to the size of the proposed sale relative to the company's share count.
The securities listed were acquired in 2021 through restricted stock vesting under a registered plan: 603 shares on 03/25/2021, 1,126 shares on 02/28/2021 and 771 shares on 03/23/2021, each noted as payment for services rendered. The filer indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Insider sale reported: Shiela Vinczeller, Chief Human Resources Officer of AptarGroup, Inc. (ATR), reported selling 1,167 shares of AptarGroup common stock on 09/05/2025 at a weighted average price of $137.9661 per share. Following the sale, the filing shows she beneficially owns 25,134 shares, held directly.
The Form 4 was signed by an attorney-in-fact on 09/08/2025 and includes an explanation that the reported price is a weighted average for multiple transactions executed between $137.85 and $138.09. The filing is a routine Section 16 disclosure of a non-derivative disposition by an officer.
AptarGroup, Inc. (ATR) filed a Form 144 reporting a proposed sale of 1,167 common shares. The sale is to be handled by Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $161,006.44 and an approximate sale date of 09/05/2025. The shares were acquired on 05/02/2025 through restricted stock vesting under a registered plan and were issued by the issuer as payment for services rendered on 05/02/2025. The filer reports no securities sold in the past three months. The filing includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.